The Fatal Overdose Reduction Act of 2025 adds a new Medicaid demonstration — the Health Engagement Hub Demonstration Program — authorizing States to certify community-based “Health Engagement Hubs” that deliver low‑threshold harm reduction, walk‑in behavioral and primary care, rapid access to medications for opioid use disorder (MOUD), and social supports. The bill directs the Secretary of Health and Human Services to publish certification criteria and guidance for a State‑level prospective payment system (PPS) for specified hub services, while preserving separate Medicaid payment rules for prescribed drugs.
Why it matters: the bill creates a concrete financing and certification pathway for a hub model designed to reach populations at high risk of overdose (including uninsured people, those experiencing homelessness, tribal communities, and rural areas). It pairs upfront planning grants with a time‑limited, federally supported demonstration (up to 10 States, five years) and requires evaluation and reporting intended to measure reach, outcomes, and equity impacts — changes that will affect Medicaid programs, behavioral health providers, community organizations, and State budgets and operations.
At a Glance
What It Does
Authorizes a new subsection to Medicaid law creating a Health Engagement Hub Demonstration Program; requires HHS guidance within 6 months on certification criteria and on how States should set a prospective payment system for specified hub services, while specifying that drug reimbursements remain payable separately under standard Medicaid rules.
Who It Affects
State Medicaid agencies (applicants and PPS designers), community health organizations and certified Hubs that treat OUD/SUD, providers supplying MOUD and outpatient drugs, Tribal entities seeking participation, and uninsured or Medicaid‑eligible individuals who use drugs.
Why It Matters
The bill establishes a financed, measurable path for low‑threshold, walk‑in services with federal support (90% federal match for PPS‑covered hub services) and reporting and evaluation requirements that could shape whether Hubs scale nationally and how Medicaid pays for integrated harm‑reduction and treatment services.
More articles like this one.
A weekly email with all the latest developments on this topic.
What This Bill Actually Does
The bill creates a new Medicaid demonstration aimed at increasing access to treatment and harm‑reduction services for opioid and other substance use disorders through certified Health Engagement Hubs. HHS must issue guidance within six months describing certification criteria for Hubs and instructions for States to develop a prospective payment system to reimburse a defined set of hub services.
The guidance must also clarify that while many hub services will be included in the PPS, Medicaid payment for prescribed drugs and covered outpatient drugs remains payable separately under existing Medicaid rules and rebate arrangements.
To qualify as a Health Engagement Hub an organization must demonstrate capacity to serve Medicaid‑eligible people (including those eligible but not enrolled), uninsured people, and to offer drop‑in, no‑appointment services. Hubs must provide harm‑reduction supplies, overdose education and naloxone distribution, walk‑in behavioral and primary care, peer supports, case management, targeted social‑needs services, and access to evidence‑based medications for OUD/SUD within four hours of arrival, either on site or through formal partnerships.
The bill prescribes minimum staffing (including prescribers, nurses, licensed behavioral health staff, and peer or recovery staff), a community advisory board with people with lived experience, and at least 12 months of organizational experience in SUD treatment.The federal government sets aside $60 million for planning grants, technical assistance, data collection, and HHS administrative costs. States that receive planning grants may apply (within nine months) to be among up to ten States selected for the demonstration; selected States will run the demonstration for five years.
The Secretary will waive Medicaid statewideness and comparability as needed for participating States. For PPS‑covered hub services, the federal share is 90 percent of State expenditures (or the higher otherwise applicable FMAP), but payments for prescribed drugs are treated separately so that Hubs can still bill Medicaid drug benefits under standard rules.
The legislation requires annual State reporting beginning in year three, a national implementation evaluation by a contracted entity, and a GAO report assessing the Secretary’s evaluation findings.
The Five Things You Need to Know
The bill appropriates $60 million to HHS for planning grants, technical assistance, data collection, and administrative costs to set up the demonstration.
HHS must publish certification criteria and PPS guidance within 6 months of enactment; States awarded planning grants have 9 months to apply to be selected.
Up to 10 States will be selected to run 5‑year demonstrations; the Secretary must prioritize States with the highest overdose death rates and ensure geographic diversity.
Certified Hubs must provide access to medications for OUD/SUD within 4 hours of a person’s arrival; prescribed drugs remain payable separately under Medicaid drug payment rules rather than being bundled into the PPS.
For PPS‑covered hub services a participating State receives 90% federal reimbursement (or its otherwise applicable FMAP if higher) for expenditures at the PPS rate; States must design and verify the PPS as part of the application.
Section-by-Section Breakdown
Every bill we cover gets an analysis of its key sections.
Authority to establish the Health Engagement Hub Demonstration
This provision directs the HHS Secretary to run a demonstration program to increase access to treatment and harm‑reduction services by establishing Health Engagement Hubs that meet Secretary‑issued criteria. It frames the program as a Medicaid demonstration under section 1903, giving HHS authority to set eligibility and operational parameters for hubs and to authorize State participation.
Guidance and timeline for certification and PPS
HHS must publish two types of guidance within six months: (A) certification criteria for organizations a State may certify as Health Engagement Hubs and (B) instructions for States to design a prospective payment system for the services that will be covered through the PPS. The guidance must also clarify how Medicaid pays separately for prescribed and covered outpatient drugs provided by hubs, and it must include tailored directions to enable Tribal applicants to apply and participate.
Certification criteria, required services, and staffing standards
This subsection lists the operational requirements to be a certified Hub: low‑threshold, drop‑in access for Medicaid‑eligible and uninsured people; core services (harm reduction, walk‑in physical and behavioral health, wound care, infectious disease screening and vaccinations, peer supports, case management, and rapid MOUD access); and minimum staffing (prescriber able to prescribe controlled substances, nurse, licensed behavioral health staff, and peer/support staff). It also requires community advisory boards with people with lived experience and at least 12 months of prior SUD treatment experience to qualify.
Planning grants, State applications, selection, and duration
The bill appropriates $60 million to fund planning grants and HHS administration. States receiving planning grants may apply to participate; HHS will select up to 10 States, prioritizing those with the highest overdose rates and geographic diversity. Selected States participate for five years. Applications must describe target populations, list participating certified Hubs, provide the proposed PPS design, and verify State commitment to pay the PPS rate.
Financing mechanics: PPS and drug payment separation
States will establish a prospective payment system for specified hub items and services, which HHS will reimburse at 90% (or the State’s otherwise applicable FMAP if higher) of State expenditures at the PPS rate. The statute explicitly prohibits bundling Medicaid payment for prescribed drugs and covered outpatient drugs into the PPS; those remain billable under standard Medicaid drug payment rules and rebate arrangements, and Hubs may receive separate Medicaid drug payments in addition to PPS revenue.
Reporting, evaluation, and oversight
States must submit implementation information during the first two years and annual reports beginning in year three, including utilization, demographics, outcomes (overdose mortality, medication adherence, hospitalization, housing status), and program recommendations. HHS must contract with an entity to conduct a national implementation evaluation that assesses reach, effectiveness, adoption, and implementation; the Secretary will include those findings in annual reports to Congress and make them public. The statute also requires cooperation from States for data collection and funds data reporting costs from the planning grant appropriation.
This bill is one of many.
Codify tracks hundreds of bills on Healthcare across all five countries.
Explore Healthcare in Codify Search →Who Benefits and Who Bears the Cost
Every bill creates winners and losers. Here's who stands to gain and who bears the cost.
Who Benefits
- Medicaid beneficiaries with opioid or other substance use disorders — the Hub model creates more low‑threshold, walk‑in access points and requires availability of evidence‑based medications within 4 hours, reducing barriers to initiation of treatment.
- Uninsured people who use drugs — Hubs must serve uninsured individuals on a sliding‑scale fee basis and cannot deny services for inability to pay, expanding access beyond Medicaid coverage.
- Community organizations and peer workforce — the statutory emphasis on peer support, community outreach, and advisory boards creates funded roles and governance influence for people with lived experience.
- Tribal entities and Urban Indian organizations — the bill explicitly directs HHS to set application requirements to enable tribes and tribal organizations to participate, creating a path for culturally specific hub models.
- Public health systems and hospitals — by providing low‑threshold care and harm reduction in the community, Hubs may reduce emergency department visits and acute care utilization among high‑risk populations.
Who Bears the Cost
- State Medicaid agencies — States must design and operationalize a PPS, verify hub certification, manage applications, and fund their share of expenditures; administrative and financial implementation burdens are concentrated at the State level.
- Certified Health Engagement Hubs and sponsoring organizations — hubs must meet staffing, facility, partnership, and reporting requirements; start‑up and operational costs (even with PPS revenue) and requirements to serve uninsured people on a sliding scale may strain small providers.
- Community providers and partners (e.g., FQHCs, pharmacies) — partnerships and contractual arrangements to supply drugs, specialized services, or staffing may bring added billing complexity and coordination costs.
- HHS/CMS — the agency must produce guidance in six months, administer planning grants, oversee selection and waivers, monitor data collection, and run evaluation contracting, demanding substantial program management resources.
- Federal budget — the 90% federal reimbursement for PPS‑covered services (or higher FMAP if applicable) plus the $60M appropriation increases federal outlays tied to State PPS claims for hub services.
Key Issues
The Core Tension
The central dilemma is between rapid, flexible, community‑based access to life‑saving SUD services (which requires local discretion, partnership networks, and flexible financing) and Medicaid’s need for fiscal controls, standardized billing, and measurable outcomes; the PPS plus separate drug payment attempts to reconcile those goals, but creates complexity that could undermine either access (if underfunded or administratively burdensome) or accountability (if too loosely specified).
Several implementation choices in the bill create practical trade‑offs. First, the prospective payment system aims to bundle payment for a broad set of hub services to incentivize integrated, low‑threshold care, but the law explicitly carves out prescribed drugs from the PPS.
That separation preserves Medicaid drug rebate and drug‑payment safeguards but creates a dual‑billing regime that will complicate claims systems, reconciliation, and budgeting for both States and hubs. States must construct PPS rates that adequately reflect the intensive outreach, peer services, and non‑clinical supports Hubs provide; if rates are set too low, hubs may be financially unsustainable, yet if rates are too generous the federal fiscal exposure rises.
Second, the statute prioritizes rapid access (MOUD within four hours) and places explicit staffing and lived‑experience requirements on hubs. Those requirements improve clinical reliability and cultural reach but collide with an existing workforce shortage in behavioral health and peer recovery roles; small or rural providers may struggle to recruit the mandated mix of staff and meet the 12‑month experience threshold.
Third, the evaluation and reporting framework is robust — it requires annual State reports and a national implementation evaluation — but meaningful outcome measurement (like reductions in overdose mortality) depends on attribution, timeline, and data quality. States and evaluators will likely face challenges in finding valid comparison groups, aligning data sources, and isolating hub effects from concurrent public health interventions.
Try it yourself.
Ask a question in plain English, or pick a topic below. Results in seconds.